LYRCX | VMVAX | LYRCX / VMVAX | |
Total Expense Ratio | 1.99 | 0.07 | 2,843% |
Annual Report Gross Expense Ratio | 2.46 | 0.07 | 3,514% |
Fund Existence | 3 years | 14 years | - |
Gain YTD | 15.187 | 6.488 | 234% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.13B | 32B | 4% |
Annual Yield % from dividends | 0.00 | 2.15 | - |
Returns for 1 year | 13.66 | 3.90 | 351% |
Returns for 3 years | 56.08 | 29.94 | 187% |
Returns for 5 years | N/A | 68.46 | - |
Returns for 10 years | N/A | 102.40 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IWV | 374.38 | -0.42 | -0.11% |
iShares Russell 3000 ETF | |||
TSMZ | 14.56 | -0.02 | -0.12% |
Direxion Daily TSM Bear 1X Shares | |||
GTEK | 38.68 | -0.09 | -0.24% |
Goldman Sachs Future Tech Leaders Eq ETF | |||
DSTX | 30.22 | -0.09 | -0.30% |
Distillate Intntnl Fndmntl Stblty&Vl ETF | |||
ECH | 33.40 | -0.36 | -1.07% |
iShares MSCI Chile ETF |